Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of biomarkers for antimalarial drug susceptibility and resistance monitoring
PACTR201508001191898Completed
- Sponsor
- European & Developing Countries Clinical Trials Partnership
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of artemether, lumefantrine, artesunate and amodiaquine in malaria and Falciparum malaria (PF) (2 arms), sponsored by European & Developing Countries Clinical Trials Partnership. Primary endpoint: Clinical outcome. Started Jan 2009; status: completed.
02
Drugs
artemetherlumefantrineartesunateamodiaquine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on PACTR201508001191898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201508001191898.